These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38149604)

  • 21. Renal masses measuring under 2 cm: pathologic outcomes and associations with MRI features.
    Rosenkrantz AB; Wehrli NE; Melamed J; Taneja SS; Shaikh MB
    Eur J Radiol; 2014 Aug; 83(8):1311-6. PubMed ID: 24882784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differentiation of Predominantly Solid Enhancing Lipid-Poor Renal Cell Masses by Use of Contrast-Enhanced CT: Evaluating the Role of Texture in Tumor Subtyping.
    Varghese BA; Chen F; Hwang DH; Cen SY; Desai B; Gill IS; Duddalwar VA
    AJR Am J Roentgenol; 2018 Dec; 211(6):W288-W296. PubMed ID: 30240299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accuracy of Contrast-enhanced US for Differentiating Benign from Malignant Solid Small Renal Masses.
    Atri M; Tabatabaeifar L; Jang HJ; Finelli A; Moshonov H; Jewett M
    Radiology; 2015 Sep; 276(3):900-8. PubMed ID: 25919803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. cT1a Renal Masses Less Than 2 versus 2 cm or Greater Managed by Robotic Partial Nephrectomy: A Propensity Score Matched Comparison of Perioperative Outcomes.
    Bertolo R; Garisto J; Dagenais J; Sagalovich D; Agudelo J; Stein R; Fareed K; Gao T; Fergany A; Kaouk J
    J Urol; 2019 Jan; 201(1):56-61. PubMed ID: 30100402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coexisting hybrid malignancy in a solitary sporadic solid benign renal mass: implications for treating patients following renal biopsy.
    Ginzburg S; Uzzo R; Al-Saleem T; Dulaimi E; Walton J; Corcoran A; Plimack E; Mehrazin R; Tomaszewski J; Viterbo R; Chen DY; Greenberg R; Smaldone M; Kutikov A
    J Urol; 2014 Feb; 191(2):296-300. PubMed ID: 23899990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Core needle biopsy clarify the histology of the small renal masses and may prevent overtreatment.
    Azawi NH; Tolouee SA; Madsen M; Berg KD; Dahl C; Fode M
    Int Urol Nephrol; 2018 Jul; 50(7):1205-1209. PubMed ID: 29846890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imaging findings of common benign renal tumors in the era of small renal masses: differential diagnosis from small renal cell carcinoma: current status and future perspectives.
    Woo S; Cho JY
    Korean J Radiol; 2015; 16(1):99-113. PubMed ID: 25598678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma.
    Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1845-1851. PubMed ID: 28451753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Should We Separate the Pulmonary Surveillance Protocol for Postsurgical T1a and T1b Renal Cell Carcinoma? A Multicenter Database Analysis.
    Chow AK; Kahan AN; Hwang T; Coogan CL; Latchamsetty KC
    Urology; 2018 Dec; 122():127-132. PubMed ID: 30205104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Qualitative and quantitative MDCT features for differentiating clear cell renal cell carcinoma from other solid renal cortical masses.
    Lee-Felker SA; Felker ER; Tan N; Margolis DJ; Young JR; Sayre J; Raman SS
    AJR Am J Roentgenol; 2014 Nov; 203(5):W516-24. PubMed ID: 25341166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of aorta-lesion-attenuation difference on preoperative contrast-enhanced computed tomography scan to differentiate between malignant and benign oncocytic renal tumors.
    Grajo JR; Batra NV; Bozorgmehri S; Magnelli LL; Pavlinec J; O'Malley P; Su LM; Crispen PL
    Abdom Radiol (NY); 2021 Jul; 46(7):3269-3279. PubMed ID: 33665734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of Benign Renal Masses in a Contemporary Cohort of Patients Receiving Partial Nephrectomy for Presumed Renal Cell Carcinoma.
    Vijay V; Vokshi FH; Smigelski M; Nagpal S; Huang WC
    Clin Genitourin Cancer; 2023 Jun; 21(3):e114-e118. PubMed ID: 36535809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An In-vivo Prospective Study of the Diagnostic Yield and Accuracy of Optical Biopsy Compared with Conventional Renal Mass Biopsy for the Diagnosis of Renal Cell Carcinoma: The Interim Analysis.
    Buijs M; Wagstaff PGK; de Bruin DM; Zondervan PJ; Savci-Heijink CD; van Delden OM; van Leeuwen TG; van Moorselaar RJA; de la Rosette JJMCH; Laguna Pes MP
    Eur Urol Focus; 2018 Dec; 4(6):978-985. PubMed ID: 29079496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-risk Disease and Poor Follow-up: The Importance of Renal Mass Biopsy in a Cohort of Veterans.
    Anishchenko K; Antoine S; Geiger C; Lenzmeier R; Kim S; Lloyd GL
    Urology; 2022 Sep; 167():152-157. PubMed ID: 35588788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histogram analysis of small solid renal masses: differentiating minimal fat angiomyolipoma from renal cell carcinoma.
    Chaudhry HS; Davenport MS; Nieman CM; Ho LM; Neville AM
    AJR Am J Roentgenol; 2012 Feb; 198(2):377-83. PubMed ID: 22268181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncological and Functional Outcomes of Laparoscopic Radiofrequency Ablation and Partial Nephrectomy for T1a Renal Masses: A Retrospective Single-center 60 Month Follow-up Cohort Study.
    Park JM; Yang SW; Shin JH; Na YG; Song KH; Lim JS
    Urol J; 2019 Feb; 16(1):44-49. PubMed ID: 30120758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of Tc-99m MIBI scintigraphy in clinical T1 renal mass assessment: Does it have a real benefit?
    Asi T; Tuncali MÇ; Tuncel M; Alkanat NEİ; Hazir B; Kösemehmetoğlu K; Baydar DE; Akdoğan B
    Urol Oncol; 2020 Dec; 38(12):937.e11-937.e17. PubMed ID: 32859460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synchronous renal and adrenal masses: an analysis of 80 cases.
    Bahrami A; Truong LD; Shen SS; Krishnan B
    Ann Diagn Pathol; 2009 Feb; 13(1):9-15. PubMed ID: 19118776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiomyolipoma being surgically excised for presumed kidney carcinoma.
    Hou W; Xiao H; Liu G; Ji Z
    Int Urol Nephrol; 2015 Jul; 47(7):1037-43. PubMed ID: 25940032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tuberose sclerosis complex: analysis of growth rates aids differentiation of renal cell carcinoma from atypical or minimal-fat-containing angiomyolipoma.
    Patel U; Simpson E; Kingswood JC; Saggar-Malik AK
    Clin Radiol; 2005 Jun; 60(6):665-73; discussion 663-4. PubMed ID: 16038693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.